{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(2)"],"submitter":["Kennon S"],"funding":["Edwards Lifesciences"],"pubmed_abstract":["<h4>Background</h4>The Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ) is a validated instrument for assessing quality of life (QoL) in patients with severe aortic stenosis (AS). In this study, we evaluated health status outcomes, based on the TASQ, in patients with severe AS undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR).<h4>Methods</h4>The TASQ registry was a prospective observational registry. Patients with severe AS from nine centres in Europe and one in Canada underwent either SAVR or transfemoral TAVR. Patients completed the TASQ, Kansas City Cardiomyopathy Questionnaire and Short Form-12 V.2 prior to the intervention, predischarge, and at 30-day and 3-month follow-ups. Primary end point was the TASQ score.<h4>Results"],"journal":["Open heart"],"pagination":["e001821"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8609945"],"repository":["biostudies-literature"],"pubmed_title":["Quality of life after transcatheter or surgical aortic valve replacement using the Toronto Aortic Stenosis Quality of Life Questionnaire."],"pmcid":["PMC8609945"],"pubmed_authors":["Luske C","Romano M","Kurucova J","Cuenca Castillo JJ","Thoenes M","Kennon S","Deutsch C","Sykorova L","Bramlage P","Styra R","Ribichini FL","Stastny L","Bonaros N","Frank D","Himbert D","Lefevre T","Urena-Alcazar M","Stefano P","Garcia B","Di Mario C","Salgado-Fernandez J"],"additional_accession":[]},"is_claimable":false,"name":"Quality of life after transcatheter or surgical aortic valve replacement using the Toronto Aortic Stenosis Quality of Life Questionnaire.","description":"<h4>Background</h4>The Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ) is a validated instrument for assessing quality of life (QoL) in patients with severe aortic stenosis (AS). In this study, we evaluated health status outcomes, based on the TASQ, in patients with severe AS undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR).<h4>Methods</h4>The TASQ registry was a prospective observational registry. Patients with severe AS from nine centres in Europe and one in Canada underwent either SAVR or transfemoral TAVR. Patients completed the TASQ, Kansas City Cardiomyopathy Questionnaire and Short Form-12 V.2 prior to the intervention, predischarge, and at 30-day and 3-month follow-ups. Primary end point was the TASQ score.<h4>Results","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Nov","modification":"2026-06-16T03:12:34.103Z","creation":"2026-06-16T03:07:12.438Z"},"accession":"S-EPMC8609945","cross_references":{"pubmed":["34810276"],"doi":["10.1136/openhrt-2021-001821"]}}